{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T22:33:37Z","timestamp":1792017217227,"version":"4.4.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81372223"],"award-info":[{"award-number":["81372223"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81422034"],"award-info":[{"award-number":["81422034"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["3157080222"],"award-info":[{"award-number":["3157080222"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Cancer"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s12943-017-0744-2","type":"journal-article","created":{"date-parts":[[2017,11,29]],"date-time":"2017-11-29T08:38:38Z","timestamp":1511944718000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":64,"title":["JMJD6 promotes melanoma carcinogenesis through regulation of the alternative splicing of PAK1, a key MAPK signaling component"],"prefix":"10.1186","volume":"16","author":[{"given":"Xujun","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenzhe","family":"Si","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinhua","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziran","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianguo","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanjin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shumeng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Pei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3917-473X","authenticated-orcid":false,"given":"Luyang","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,11,29]]},"reference":[{"key":"744_CR1","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S1535-6108(02)00161-7","volume":"2","author":"AN Houghton","year":"2002","unstructured":"Houghton AN, Polsky D. Focus on melanoma. Cancer Cell. 2002;2:275\u20138.","journal-title":"Cancer Cell"},{"key":"744_CR2","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/1741-7015-10-23","volume":"10","author":"L Finn","year":"2012","unstructured":"Finn L, Markovic SN, Joseph RW. Therapy for metastatic melanoma: the past, present, and future. BMC Med. 2012;10:23.","journal-title":"BMC Med"},{"key":"744_CR3","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1038\/nature00766","volume":"417","author":"H Davies","year":"2002","unstructured":"Davies H, Bignell GR, Cox C, Stephens P, Edkins S, Clegg S, Teague J, Woffendin H, Garnett MJ, Bottomley W, et al. Mutations of the BRAF gene in human cancer. Nature. 2002;417:949\u201354.","journal-title":"Nature"},{"key":"744_CR4","doi-asserted-by":"crossref","first-page":"6031","DOI":"10.1038\/sj.onc.1207812","volume":"23","author":"H Sumimoto","year":"2004","unstructured":"Sumimoto H, Miyagishi M, Miyoshi H, Yamagata S, Shimizu A, Taira K, Kawakami Y. Inhibition of growth and invasive ability of melanoma by inactivation of mutated BRAF with lentivirus-mediated RNA interference. Oncogene. 2004;23:6031\u20139.","journal-title":"Oncogene"},{"key":"744_CR5","doi-asserted-by":"crossref","first-page":"14843","DOI":"10.1074\/jbc.270.25.14843","volume":"270","author":"MH Cobb","year":"1995","unstructured":"Cobb MH, Goldsmith EJ. How MAP kinases are regulated. J Biol Chem. 1995;270:14843\u20136.","journal-title":"J Biol Chem"},{"key":"744_CR6","doi-asserted-by":"crossref","first-page":"2056","DOI":"10.1093\/emboj\/19.9.2056","volume":"19","author":"L Bakiri","year":"2000","unstructured":"Bakiri L, Lallemand D, Bossy-Wetzel E, Yaniv M. Cell cycle-dependent variations in c-Jun and JunB phosphorylation: a role in the control of cyclin D1 expression. EMBO J. 2000;19:2056\u201368.","journal-title":"EMBO J"},{"key":"744_CR7","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1111\/cas.12676","volume":"106","author":"M Kamiyama","year":"2015","unstructured":"Kamiyama M, Naguro I, Ichijo H. In vivo gene manipulation reveals the impact of stress-responsive MAPK pathways on tumor progression. Cancer Sci. 2015;106:785\u201396.","journal-title":"Cancer Sci"},{"key":"744_CR8","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.canlet.2013.11.019","volume":"344","author":"X Sui","year":"2014","unstructured":"Sui X, Kong N, Ye L, Han W, Zhou J, Zhang Q, He C, Pan H. p38 and JNK MAPK pathways control the balance of apoptosis and autophagy in response to chemotherapeutic agents. Cancer Lett. 2014;344:174\u20139.","journal-title":"Cancer Lett"},{"key":"744_CR9","doi-asserted-by":"crossref","first-page":"6382","DOI":"10.1158\/0008-5472.CAN-12-1033","volume":"72","author":"MB Weiss","year":"2012","unstructured":"Weiss MB, Abel EV, Mayberry MM, Basile KJ, Berger AC, Aplin AE. TWIST1 is an ERK1\/2 effector that promotes invasion and regulates MMP-1 expression in human melanoma cells. Cancer Res. 2012;72:6382\u201392.","journal-title":"Cancer Res"},{"key":"744_CR10","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1002\/(SICI)1097-0215(19990719)82:2<268::AID-IJC18>3.0.CO;2-4","volume":"82","author":"KB Reddy","year":"1999","unstructured":"Reddy KB, Krueger JS, Kondapaka SB, Diglio CA. Mitogen-activated protein kinase (MAPK) regulates the expression of progelatinase B (MMP-9) in breast epithelial cells. Int J Cancer. 1999;82:268\u201373.","journal-title":"Int J Cancer"},{"key":"744_CR11","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/35011084","volume":"405","author":"VA Fadok","year":"2000","unstructured":"Fadok VA, Bratton DL, Rose DM, Pearson A, Ezekewitz RA, Henson PM. A receptor for phosphatidylserine-specific clearance of apoptotic cells. Nature. 2000;405:85\u201390.","journal-title":"Nature"},{"key":"744_CR12","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1126\/science.1145801","volume":"318","author":"B Chang","year":"2007","unstructured":"Chang B, Chen Y, Zhao Y, Bruick RK. JMJD6 is a histone arginine demethylase. Science. 2007;318:444\u20137.","journal-title":"Science"},{"key":"744_CR13","doi-asserted-by":"crossref","first-page":"e1001819","DOI":"10.1371\/journal.pbio.1001819","volume":"12","author":"F Wang","year":"2014","unstructured":"Wang F, He L, Huangyang P, Liang J, Si W, Yan R, Han X, Liu S, Gui B, Li W, et al. JMJD6 promotes colon carcinogenesis through negative regulation of p53 by hydroxylation. PLoS Biol. 2014;12:e1001819.","journal-title":"PLoS Biol"},{"key":"744_CR14","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1126\/science.1175865","volume":"325","author":"CJ Webby","year":"2009","unstructured":"Webby CJ, Wolf A, Gromak N, Dreger M, Kramer H, Kessler B, Nielsen ML, Schmitz C, Butler DS, Yates JR 3rd, et al. Jmjd6 catalyses lysyl-hydroxylation of U2AF65, a protein associated with RNA splicing. Science. 2009;325:90\u20133.","journal-title":"Science"},{"key":"744_CR15","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1126\/science.1087621","volume":"302","author":"MO Li","year":"2003","unstructured":"Li MO, Sarkisian MR, Mehal WZ, Rakic P, Flavell RA. Phosphatidylserine receptor is required for clearance of apoptotic cells. Science. 2003;302:1560\u20133.","journal-title":"Science"},{"key":"744_CR16","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/jbiol10","volume":"3","author":"J Bose","year":"2004","unstructured":"Bose J, Gruber AD, Helming L, Schiebe S, Wegener I, Hafner M, Beales M, Kontgen F, Lengeling A. The phosphatidylserine receptor has essential functions during embryogenesis but not in apoptotic cell removal. J Biol. 2004;3:15.","journal-title":"J Biol"},{"key":"744_CR17","doi-asserted-by":"crossref","first-page":"3362","DOI":"10.1182\/blood-2003-09-3245","volume":"103","author":"Y Kunisaki","year":"2004","unstructured":"Kunisaki Y, Masuko S, Noda M, Inayoshi A, Sanui T, Harada M, Sasazuki T, Fukui Y. Defective fetal liver erythropoiesis and T lymphopoiesis in mice lacking the phosphatidylserine receptor. Blood. 2004;103:3362\u20134.","journal-title":"Blood"},{"key":"744_CR18","first-page":"R85","volume":"14","author":"YF Lee","year":"2012","unstructured":"Lee YF, Miller LD, Chan XB, Black MA, Pang B, Ong CW, Salto-Tellez M, Liu ET, Desai KV. JMJD6 is a driver of cellular proliferation and motility and a marker of poor prognosis in breast cancer. Breast Cancer Res. 2012;14:R85.","journal-title":"Breast Cancer Res"},{"key":"744_CR19","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.1007\/s13277-013-0789-9","volume":"34","author":"J Zhang","year":"2013","unstructured":"Zhang J, Ni SS, Zhao WL, Dong XC, Wang JL. High expression of JMJD6 predicts unfavorable survival in lung adenocarcinoma. Tumour Biol. 2013;34:2397\u2013401.","journal-title":"Tumour Biol"},{"key":"744_CR20","doi-asserted-by":"crossref","first-page":"5541","DOI":"10.1021\/bi3007065","volume":"51","author":"KF Mittendorf","year":"2012","unstructured":"Mittendorf KF, Deatherage CL, Ohi MD, Sanders CR. Tailoring of membrane proteins by alternative splicing of pre-mRNA. Biochemistry. 2012;51:5541\u201356.","journal-title":"Biochemistry"},{"key":"744_CR21","doi-asserted-by":"crossref","unstructured":"Kozlovski I, Siegfried Z, Amar-Schwartz A, Karni R. The role of RNA alternative splicing in regulating cancer metabolism. Hum Genet. 2017;136:1113\u201327.","DOI":"10.1007\/s00439-017-1803-x"},{"key":"744_CR22","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1038\/nature08697","volume":"463","author":"CJ David","year":"2010","unstructured":"David CJ, Chen M, Assanah M, Canoll P, Manley JL. HnRNP proteins controlled by c-Myc deregulate pyruvate kinase mRNA splicing in cancer. Nature. 2010;463:364\u20138.","journal-title":"Nature"},{"key":"744_CR23","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.bbrc.2011.08.098","volume":"413","author":"N Okumura","year":"2011","unstructured":"Okumura N, Yoshida H, Kitagishi Y, Nishimura Y, Matsuda S. Alternative splicings on p53, BRCA1 and PTEN genes involved in breast cancer. Biochem Biophys Res Commun. 2011;413:395\u20139.","journal-title":"Biochem Biophys Res Commun"},{"key":"744_CR24","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1042\/BST20120140","volume":"40","author":"C Tammaro","year":"2012","unstructured":"Tammaro C, Raponi M, Wilson DI, Baralle D. BRCA1 exon 11 alternative splicing, multiple functions and the association with cancer. Biochem Soc Trans. 2012;40:768\u201372.","journal-title":"Biochem Soc Trans"},{"key":"744_CR25","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1111\/j.1742-4658.2011.08426.x","volume":"279","author":"J Zhong","year":"2012","unstructured":"Zhong J, Cao RX, XY Z, Hong T, Yang J, Liu L, Xiao XH, Ding WJ, Zhao Q, Liu JH, Wen GB. Identification and characterization of novel spliced variants of PRMT2 in breast carcinoma. FEBS J. 2012;279:316\u201335.","journal-title":"FEBS J"},{"key":"744_CR26","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.molonc.2007.05.002","volume":"1","author":"PA Usher","year":"2007","unstructured":"Usher PA, Sieuwerts AM, Bartels A, Lademann U, Nielsen HJ, Holten-Andersen L, Foekens JA, Brunner N, Offenberg H. Identification of alternatively spliced TIMP-1 mRNA in cancer cell lines and colon cancer tissue. Mol Oncol. 2007;1:205\u201315.","journal-title":"Mol Oncol"},{"key":"744_CR27","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1097\/JTO.0b013e3181a520dc","volume":"4","author":"R Pio","year":"2009","unstructured":"Pio R, Montuenga LM. Alternative splicing in lung cancer. J Thorac Oncol. 2009;4:674\u20138.","journal-title":"J Thorac Oncol"},{"key":"744_CR28","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1093\/carcin\/bgp098","volume":"30","author":"D Moretti","year":"2009","unstructured":"Moretti D, Del Bello B, Cosci E, Biagioli M, Miracco C, Maellaro E. Novel variants of muscle calpain 3 identified in human melanoma cells: cisplatin-induced changes in vitro and differential expression in melanocytic lesions. Carcinogenesis. 2009;30:960\u20137.","journal-title":"Carcinogenesis"},{"key":"744_CR29","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1084\/jem.182.1.155","volume":"182","author":"AL Angiolillo","year":"1995","unstructured":"Angiolillo AL, Sgadari C, Taub DD, Liao F, Farber JM, Maheshwari S, Kleinman HK, Reaman GH, Tosato G. Human interferon-inducible protein 10 is a potent inhibitor of angiogenesis in vivo. J Exp Med. 1995;182:155\u201362.","journal-title":"J Exp Med"},{"key":"744_CR30","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1158\/2159-8290.CD-12-0095","volume":"2","author":"E Cerami","year":"2012","unstructured":"Cerami E, Gao J, Dogrusoz U, Gross BE, Sumer SO, Aksoy BA, Jacobsen A, Byrne CJ, Heuer ML, Larsson E, et al. The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discov. 2012;2:401\u20134.","journal-title":"Cancer Discov"},{"key":"744_CR31","doi-asserted-by":"crossref","first-page":"10662","DOI":"10.1093\/nar\/gkw808","volume":"44","author":"J Wan","year":"2016","unstructured":"Wan J, Xu W, Zhan J, Ma J, Li X, Xie Y, Wang J, Zhu WG, Luo J, Zhang H. PCAF-mediated acetylation of transcriptional factor HOXB9 suppresses lung adenocarcinoma progression by targeting oncogenic protein JMJD6. Nucleic Acids Res. 2016;44:10662\u201375.","journal-title":"Nucleic Acids Res"},{"key":"744_CR32","doi-asserted-by":"crossref","first-page":"4395","DOI":"10.1074\/jbc.M110000200","volume":"277","author":"M Zang","year":"2002","unstructured":"Zang M, Hayne C, Luo Z. Interaction between active Pak1 and Raf-1 is necessary for phosphorylation and activation of Raf-1. J Biol Chem. 2002;277:4395\u2013405.","journal-title":"J Biol Chem"},{"key":"744_CR33","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1083\/jcb.200212141","volume":"162","author":"JK Slack-Davis","year":"2003","unstructured":"Slack-Davis JK, Eblen ST, Zecevic M, Boerner SA, Tarcsafalvi A, Diaz HB, Marshall MS, Weber MJ, Parsons JT, Catling AD. PAK1 phosphorylation of MEK1 regulates fibronectin-stimulated MAPK activation. J Cell Biol. 2003;162:281\u201391.","journal-title":"J Cell Biol"},{"key":"744_CR34","doi-asserted-by":"crossref","first-page":"11221","DOI":"10.1074\/jbc.M210318200","volume":"278","author":"NH Tran","year":"2003","unstructured":"Tran NH, Frost JA. Phosphorylation of Raf-1 by p21-activated kinase 1 and Src regulates Raf-1 autoinhibition. J Biol Chem. 2003;278:11221\u20136.","journal-title":"J Biol Chem"},{"key":"744_CR35","doi-asserted-by":"crossref","first-page":"3397","DOI":"10.1038\/onc.2011.515","volume":"31","author":"Y Shrestha","year":"2012","unstructured":"Shrestha Y, Schafer EJ, Boehm JS, Thomas SR, He F, Du J, Wang S, Barretina J, Weir BA, Zhao JJ, et al. PAK1 is a breast cancer oncogene that coordinately activates MAPK and MET signaling. Oncogene. 2012;31:3397\u2013408.","journal-title":"Oncogene"},{"key":"744_CR36","doi-asserted-by":"crossref","unstructured":"Yi J, Shen HF, Qiu JS, Huang MF, Zhang WJ, Ding JC, Zhu XY, Zhou Y, XD F, Liu W. JMJD6 and U2AF65 co-regulate alternative splicing in both JMJD6 enzymatic activity dependent and independent manner. Nucleic Acids Res. 2016;45:3503\u201318.","DOI":"10.1093\/nar\/gkw1144"},{"key":"744_CR37","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.gene.2016.12.014","volume":"605","author":"R Kumar","year":"2017","unstructured":"Kumar R, Sanawar R, Li X, Li F. Structure, biochemistry, and biology of PAK kinases. Gene. 2017;605:20\u201331.","journal-title":"Gene"},{"key":"744_CR38","doi-asserted-by":"crossref","first-page":"e2734","DOI":"10.1371\/journal.pone.0002734","volume":"3","author":"C Wellbrock","year":"2008","unstructured":"Wellbrock C, Rana S, Paterson H, Pickersgill H, Brummelkamp T, Marais R, Oncogenic BRAF. Regulates melanoma proliferation through the lineage specific factor MITF. PLoS One. 2008;3:e2734.","journal-title":"PLoS One"},{"key":"744_CR39","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1038\/nature12688","volume":"504","author":"CM Johannessen","year":"2013","unstructured":"Johannessen CM, Johnson LA, Piccioni F, Townes A, Frederick DT, Donahue MK, Narayan R, Flaherty KT, Wargo JA, Root DE, Garraway LA. A melanocyte lineage program confers resistance to MAP kinase pathway inhibition. Nature. 2013;504:138\u201342.","journal-title":"Nature"},{"key":"744_CR40","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1002\/mc.22407","volume":"55","author":"WR Lee","year":"2016","unstructured":"Lee WR, Shen SC, PR W, Chou CL, Shih YH, Yeh CM, Yeh KT, Jiang MC. CSE1L links cAMP\/PKA and Ras\/ERK pathways and regulates the expressions and phosphorylations of ERK1\/2, CREB, and MITF in melanoma cells. Mol Carcinog. 2016;55:1542\u201352.","journal-title":"Mol Carcinog"},{"key":"744_CR41","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1038\/nrm3758","volume":"15","author":"S Lamouille","year":"2014","unstructured":"Lamouille S, Xu J, Derynck R. Molecular mechanisms of epithelial-mesenchymal transition. Nat Rev Mol Cell Biol. 2014;15:178\u201396.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"744_CR42","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144:646\u201374.","journal-title":"Cell"},{"key":"744_CR43","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1186\/s13287-016-0377-1","volume":"7","author":"J Chen","year":"2016","unstructured":"Chen J, Gu Z, Wu M, Yang Y, Zhang J, Ou J, Zuo Z, Wang J, Chen Y. C-reactive protein can upregulate VEGF expression to promote ADSC-induced angiogenesis by activating HIF-1alpha via CD64\/PI3k\/Akt and MAPK\/ERK signaling pathways. Stem Cell Res Ther. 2016;7:114.","journal-title":"Stem Cell Res Ther"},{"key":"744_CR44","doi-asserted-by":"crossref","first-page":"2462","DOI":"10.1016\/j.jid.2016.07.024","volume":"136","author":"D Kumar","year":"2016","unstructured":"Kumar D, Kumar S, Gorain M, Tomar D, Patil HS, Radharani NN, Kumar TV, Patil TV, Thulasiram HV, Kundu GC. Notch1-MAPK signaling Axis regulates CD133+ cancer stem cell-mediated melanoma growth and angiogenesis. J Invest Dermatol. 2016;136:2462\u201374.","journal-title":"J Invest Dermatol"},{"key":"744_CR45","doi-asserted-by":"crossref","unstructured":"Mu X, Zhao T, Xu C, Shi W, Geng B, Shen J, Zhang C, Pan J, Yang J, Hu S, et al. Oncometabolite succinate promotes angiogenesis by upregulating VEGF expression through GPR91-mediated STAT3 and ERK activation. Oncotarget. 2017;8:13174\u201385.","DOI":"10.18632\/oncotarget.14485"},{"key":"744_CR46","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1002\/aja.1001740403","volume":"174","author":"DS Grant","year":"1985","unstructured":"Grant DS, Kleinman HK, Leblond CP, Inoue S, Chung AE, Martin GR. The basement-membrane-like matrix of the mouse EHS tumor: II. Immunohistochemical quantitation of six of its components. Am J Anat. 1985;174:387\u201398.","journal-title":"Am J Anat"},{"key":"744_CR47","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1016\/j.bbamcr.2007.01.002","volume":"1773","author":"M Katz","year":"2007","unstructured":"Katz M, Amit I, Yarden Y. Regulation of MAPKs by growth factors and receptor tyrosine kinases. Biochim Biophys Acta. 2007;1773:1161\u201376.","journal-title":"Biochim Biophys Acta"},{"key":"744_CR48","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.5858\/arpa.2015-0475-RS","volume":"140","author":"AM Acosta","year":"2016","unstructured":"Acosta AM, Kadkol SS. Mitogen-activated protein Kinase signaling pathway in Cutaneous melanoma: an updated review. Arch Pathol Lab Med. 2016;140:1290\u20136.","journal-title":"Arch Pathol Lab Med"},{"key":"744_CR49","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1097\/PAP.0000000000000113","volume":"23","author":"B Mitchell","year":"2016","unstructured":"Mitchell B, Dhingra JK, Mahalingam M. BRAF and epithelial-Mesenchymal transition: lessons from papillary thyroid carcinoma and primary Cutaneous melanoma. Adv Anat Pathol. 2016;23:244\u201371.","journal-title":"Adv Anat Pathol"},{"key":"744_CR50","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/s13148-016-0205-6","volume":"8","author":"O Aprelikova","year":"2016","unstructured":"Aprelikova O, Chen K, El Touny LH, Brignatz-Guittard C, Han J, Qiu T, Yang HH, Lee MP, Zhu M, Green JE. The epigenetic modifier JMJD6 is amplified in mammary tumors and cooperates with c-Myc to enhance cellular transformation, tumor progression, and metastasis. Clin Epigenetics. 2016;8:38.","journal-title":"Clin Epigenetics"}],"container-title":["Molecular Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12943-017-0744-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,11,29]],"date-time":"2017-11-29T08:42:29Z","timestamp":1511944949000},"score":1,"resource":{"primary":{"URL":"https:\/\/molecular-cancer.biomedcentral.com\/articles\/10.1186\/s12943-017-0744-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11,29]]},"references-count":50,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["744"],"URL":"https:\/\/doi.org\/10.1186\/s12943-017-0744-2","relation":{},"ISSN":["1476-4598"],"issn-type":[{"value":"1476-4598","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,11,29]]},"article-number":"175"}}